RxDoctor Payments Data

Matthew Mates, PA

Physician Assistant · Middleburg Heights, OHNPI 1033188933

Payments from drug & device makers

$3,978in general payments, 2019–2025

Across 209 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$593
  • Bayer$339
  • Blue Earth Diagnostics$338
  • Convatec Inc.$267
  • Antares Pharma, Inc.$251
  • Progenics Pharmaceuticals, Inc.$224
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$3,89598%
  • Education$832%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,978 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$100,904
Medicare patients
592
Services billed
2,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron29$23,880
GemtesaVibegron19$14,446
Tamsulosin Hcl625$8,912
Testosterone17$2,422
Finasteride241$1,911
Oxybutynin Chloride ErOxybutynin Chloride62$1,651
Trospium Chloride17$891
NitrofurantoinNitrofurantoin Macrocrystal36$871
Solifenacin Succinate22$848
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst68$740
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$362
Testosterone Cypionate11$359
Ciprofloxacin Hcl62$320
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim63$247
Alfuzosin Hcl ErAlfuzosin Hcl14$206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$593$23,88029 claims
Sumitomo Pharma America, Inc.Gemtesa$105$14,44619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Middleburg Heights

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →